Do analysts prefer CRON or ACB?

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts plainly believe Cronos Group is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate CGC or CRON?

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Do analysts rate OGI or CRON?

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 16.36%. Given Cronos Group's higher possible upside, analysts plainly believe Cronos Group is more favorable than Organigram Global. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Which has stronger earnings & valuation, SNDL or CRON?

Cronos Group has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.50 -$11.29M -$0.03 N/A Cronos Group $146.59M 7.00 -$9.45M $0.01 275.00

Is SNDL or CRON more profitable?

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% Cronos Group -1.14% -1.26% -1.20%

Cronos Group (CRON) Competitors

$2.75 0.00 (0.00%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$2.74 -0.02 (-0.55%)

As of 07/13/2026 07:55 PM Eastern

Compare

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

Should you buy Cronos Group stock or one of its competitors? MarketBeat compares Cronos Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Cronos Group compare to Aurora Cannabis?

Cronos Group (NASDAQ:CRON) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Cronos Group has a beta of 0.89, suggesting that its share price is 11% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

In the previous week, Aurora Cannabis had 5 more articles in the media than Cronos Group. MarketBeat recorded 6 mentions for Aurora Cannabis and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.96 beat Aurora Cannabis' score of 0.24 indicating that Cronos Group is being referred to more favorably in the media.

Company	Overall Sentiment
Cronos Group	Positive
Aurora Cannabis	Neutral

Cronos Group has a net margin of -1.14% compared to Aurora Cannabis' net margin of -33.57%. Aurora Cannabis' return on equity of 0.10% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.14%	-1.26%	-1.20%
Aurora Cannabis	-33.57%	0.10%	0.07%

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Cronos Group has higher earnings, but lower revenue than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00
Aurora Cannabis	$247.82M	0.66	-$88.13M	-$1.56	N/A

Cronos Group currently has a consensus target price of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher probable upside, research analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Cronos Group beats Aurora Cannabis on 11 of the 16 factors compared between the two stocks.

How does Cronos Group compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment.

In the previous week, Canopy Growth had 6 more articles in the media than Cronos Group. MarketBeat recorded 7 mentions for Canopy Growth and 1 mentions for Cronos Group. Canopy Growth's average media sentiment score of 1.10 beat Cronos Group's score of 0.96 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Positive
Cronos Group	Positive

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Comparatively, 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cronos Group has a consensus target price of $2.30, indicating a potential downside of 16.36%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts plainly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Canopy Growth has a beta of 0.79, indicating that its stock price is 21% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.72	-$190.29M	-$0.59	N/A
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -75.27%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Cronos Group	-1.14%	-1.26%	-1.20%

Summary

Cronos Group beats Canopy Growth on 12 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Organigram Global?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Comparatively, 7.8% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$185.07M	0.68	-$17.70M	-$0.13	N/A
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00

In the previous week, Organigram Global and Organigram Global both had 1 articles in the media. Organigram Global's average media sentiment score of 1.89 beat Cronos Group's score of 0.96 indicating that Organigram Global is being referred to more favorably in the media.

Company	Overall Sentiment
Organigram Global	Very Positive
Cronos Group	Positive

Organigram Global has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.41%	-9.09%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 16.36%. Given Cronos Group's higher possible upside, analysts plainly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats Organigram Global on 9 of the 14 factors compared between the two stocks.

How does Cronos Group compare to SNDL?

SNDL (NASDAQ:SNDL) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Cronos Group has a net margin of -1.14% compared to SNDL's net margin of -1.19%. SNDL's return on equity of -1.02% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has lower revenue, but higher earnings than SNDL. SNDL is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.50	-$11.29M	-$0.03	N/A
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00

8.7% of Cronos Group shares are owned by institutional investors. 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

SNDL has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

SNDL presently has a consensus price target of $5.00, suggesting a potential upside of 281.68%. Cronos Group has a consensus price target of $2.30, suggesting a potential downside of 16.36%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, SNDL and SNDL both had 1 articles in the media. SNDL's average media sentiment score of 1.87 beat Cronos Group's score of 0.96 indicating that SNDL is being referred to more favorably in the media.

Company	Overall Sentiment
SNDL	Very Positive
Cronos Group	Positive

Summary

Cronos Group beats SNDL on 9 of the 15 factors compared between the two stocks.

How does Cronos Group compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Tilray Brands has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, meaning that its share price is 11% less volatile than the broader market.

Cronos Group has lower revenue, but higher earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.63	-$2.19B	-$13.65	N/A
Cronos Group	$146.59M	7.00	-$9.45M	$0.01	275.00

In the previous week, Tilray Brands had 22 more articles in the media than Cronos Group. MarketBeat recorded 23 mentions for Tilray Brands and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.96 beat Tilray Brands' score of 0.78 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Tilray Brands	Positive
Cronos Group	Positive

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cronos Group has a net margin of -1.14% compared to Tilray Brands' net margin of -156.51%. Cronos Group's return on equity of -1.26% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Cronos Group	-1.14%	-1.26%	-1.20%

Tilray Brands presently has a consensus target price of $11.50, indicating a potential upside of 157.85%. Cronos Group has a consensus target price of $2.30, indicating a potential downside of 16.36%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats Tilray Brands on 9 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRON vs. The Competition

Export

Metric	Cronos Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.03B	$3.05B	$7.05B	$12.61B
Dividend Yield	N/A	2.06%	2.68%	8.00%
P/E Ratio	275.28	19.17	27.11	24.26
Price / Sales	7.00	838.79	587.92	117.88
Price / Cash	219.35	56.80	29.22	49.36
Price / Book	0.92	4.22	10.75	6.29
Net Income	-$9.45M	$64.26M	$3.58B	$330.66M
7 Day Performance	N/A	-3.58%	-2.06%	-1.32%
1 Month Performance	2.61%	2.12%	3.32%	-0.64%
1 Year Performance	32.85%	20.35%	26.36%	19.08%

Cronos Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRON Cronos Group	1.6134 of 5 stars	$2.75 flat	$2.30 -16.4%	+31.6%	$1.03B	$146.59M	275.28	450
ACB Aurora Cannabis	1.3295 of 5 stars	$2.71 -4.6%	N/A	-40.5%	$174.22M	$247.82M	N/A	1,028
CGC Canopy Growth	1.3239 of 5 stars	$0.96 -4.0%	N/A	-15.0%	$448.42M	$251.01M	N/A	1,128	Positive News
OGI Organigram Global	1.4543 of 5 stars	$0.99 -4.0%	N/A	-38.2%	$145.05M	$185.07M	N/A	1,139	Positive News
SNDL SNDL	4.2232 of 5 stars	$1.30 -5.5%	$5.00 +284.6%	-5.8%	$353.92M	$677.32M	N/A	2,751	News Coverage Positive News High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRON) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Summary

How does Cronos Group compare to Canopy Growth?

Summary

How does Cronos Group compare to Organigram Global?

Summary

How does Cronos Group compare to SNDL?

Summary

How does Cronos Group compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cronos Group (CRON) Competitors

CRON vs. ACB, CGC, OGI, SNDL, and TLRY

How does Cronos Group compare to Aurora Cannabis?

Which has more risk and volatility, CRON or ACB?

Does the media prefer CRON or ACB?

Is CRON or ACB more profitable?

Do institutionals and insiders believe in CRON or ACB?

Which has stronger earnings and valuation, CRON or ACB?

Do analysts prefer CRON or ACB?

Summary

How does Cronos Group compare to Canopy Growth?

Does the media refer more to CGC or CRON?

Do institutionals & insiders have more ownership in CGC or CRON?

Do analysts rate CGC or CRON?

Which has more volatility and risk, CGC or CRON?

Which has higher earnings & valuation, CGC or CRON?

Is CGC or CRON more profitable?

Summary

How does Cronos Group compare to Organigram Global?

Do institutionals & insiders hold more shares of OGI or CRON?

Which has preferable earnings & valuation, OGI or CRON?

Does the media favor OGI or CRON?

Which has more volatility and risk, OGI or CRON?

Is OGI or CRON more profitable?

Do analysts rate OGI or CRON?

Summary

How does Cronos Group compare to SNDL?

Is SNDL or CRON more profitable?

Which has stronger earnings & valuation, SNDL or CRON?

Do institutionals and insiders hold more shares of SNDL or CRON?

Which has more volatility & risk, SNDL or CRON?

Do analysts recommend SNDL or CRON?

Does the media refer more to SNDL or CRON?

Summary

How does Cronos Group compare to Tilray Brands?

Which has more risk & volatility, TLRY or CRON?

Which has better valuation & earnings, TLRY or CRON?

Does the media favor TLRY or CRON?

Do insiders and institutionals believe in TLRY or CRON?

Is TLRY or CRON more profitable?

Do analysts recommend TLRY or CRON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CRON vs. The Competition

Cronos Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools